Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.
Level 5 - mechanism / opinion, no new human data
Narrative review of preclinical and mechanistic literature without primary human data or systematic review methodology.
PubMed 27195673 · doi:10.1038/cddis.2016.132
What was done
This narrative review summarizes literature regarding the roles of fatty acid oxidation and carnitine palmitoyltransferase I (CPTI) in tumor cell metabolic adaptation, growth, gene expression, and apoptosis regulation.
What was found
The abstract reports no quantitative data, statistics, or effect sizes. It qualitatively describes CPTI as the rate-limiting enzyme delivering long-chain fatty acids into mitochondria for fatty acid oxidation, which supplies cancer cells with ATP and NADPH and interacts with pathways controlling gene expression and cell survival.
Why it matters
It highlights fatty acid oxidation and CPTI as central components of cancer metabolic rewiring and outlines the mechanistic rationale for targeting this pathway therapeutically.
Limits
The abstract contains no primary experimental data, quantitative meta-analyses, or clinical trial outcomes. As a narrative review, it reflects theoretical and mechanistic concepts without systematic search criteria or human outcome evaluations.
Cited by
- supports Carnitine palmitoyltransferase (CPT) acts as the critical gatekeeper enzyme transporting fatty acids into the mitochondria for oxidation.